Monday, December 19, 2022 Daily Archives

AGC and Gore enter Protein A-based partnership

AGC Biologics and Gore have teamed up to improve downstream purification processes by using increased productivity of the Protein A step. The collaboration between contract development manufacturing organization (CDMO) AGC and W.L Gore & Associates (Gore) includes the entirety of GORE Protein Capture Devices with protein A, which the firm says advances productivity in Protein A purification. “The goal of this collaboration is to combine the expertise of two industry leaders, enabling them to work together to optimize a long-standing…

Digitization: Biopharma must keep up with rest of the world, says Cytiva

“You can watch your pizza’s progress on an app, but our customers cannot watch their batches of cells being cultured or have simple access batch data,” says Cytiva CEO Emmanuel Ligner. Welcome to the second section of BioProcess Insider’s two-part interview with Emmanuel Ligner, who has served as CEO of Cytiva since 2017. If you have not yet read the first part where Ligner discusses how messenger RNA (mRNA) will play a major role in healthcare in 2023 and beyond,…

Andelyn to make first infantile neuroaxonal dystrophy gene therapy

Andelyn Biosciences has partnered with the INADcure Foundation to bring the first-ever gene therapy for Infantile Neuroaxonal Dystrophy (INAD) to clinical trials. Contract development manufacturing organization (CDMO) Andelyn will deliver adeno associated-associated virus vectors (AAV) in a ready-to-use format to the INADcure Foundation. The foundation was formed in 2017 to accelerate development for the treatment of INAD and other types of PLA2G6-related neurodegeneration (PLAN). “Andelyn will manufacture the gene therapy under GMP and sterile conditions in specially qualified cleanrooms,” a…

Catalent to inject $40m to expand biologics services in NC

Catalent says it will invest up to $40 million to fit its 80,000 square-foot Durham, North Caroline facility with automation and digitization capabilities. Contract development manufacturing organization (CDMO) Catalent will establish a biologics analytical center in North Carolina’s Research Triangle (RTP) to provide its clients with standalone testing for biologic drug modalities, cell and gene therapies, and analytical development. “The new Durham facility, which was already purpose-built as laboratory space, will first need to be fitted out to meet the…